A Light Prospect

Diabetes-Supply Company Receives Funding to Develop Implantable Monitor

| Nov 1, 2001

On August 1, pump maker Animas Corporation received the Advanced Technology Program (ATP) award for its long-term implantable optical blood glucose monitor.

Animas of Frazer, Pennsylvania, will collaborate with Sarnoff Corporation of Princeton, New Jersey, to develop the sensor. Sarnoff will be responsible for the development of a mid-infrared diode array for the monitor. Animas has been developing the sensor since 1996.

Katherine Crothall, PhD, CEO of Animas, said in the company's press release, "If the company is successful at the development of this monitoring technology, it could literally change the standard of care of diabetes by virtually eradicating extreme glycemic conditions and allowing patients to obtain better control of their blood sugar. Furthermore, in conjunction with an insulin pump, an accurate continuous glucose monitor could allow closed-loop control of blood sugar, thereby in essence creating an artificial pancreas.''

Animas will also receive an additional $3.18 million toward funding of the sensor. Crothall added, "The ATP award is extremely significant to Animas as it provides additional funding for this program that might otherwise be difficult to fund fully in the private-equity markets."

For additional information visit Animas's Web site at animascorp.com.

Click Here To View Or Post Comments

Categories: Artificial Pancreas, Blood Glucose, Blood Sugar, CGMs, Diabetes, Diabetes, Insulin, Insulin Pumps, Monitoring

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (1)

You May Also Be Interested In...


Posted by Anonymous on 20 November 2007

You asked, What is going on over there? Answer is, Animas is now owned by J&J-so nothing will happen because J&J is a really poor R&D company. It's a shame, too. I got the Animas Pump before J&J bought them-now I wish I hadn't because support will slide.

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.